Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Sr. Scientist at Biogen
Dr. Stolee leads the antisense oligonucleotide analytical development group at Biogen, a Massachusetts-based biotechnology company focused on neurological diseases. Her group supports oligonucleotide process development and manufacturing and is responsible for evaluating and implementing new technologies for oligonucleotide analysis. Dr. Stolee was one of the primary authors of the CMC portion of Biogen’s first oligonucleotide NDA (Spinraza) and continues to support the global filings. Prior to her current role, Dr. Stolee provided analytical support to the pharmaceutical pipeline at Biogen. She received her Ph.D. in Chemistry from George Washington University where her work focused on the development of novel ionization methods for mass spectrometry.